deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT01954316

A Study of CFI-400945 Fumarate in Patients With Advanced Cancer

An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-400945 Fumarate Administered Orally to Patients With Advanced Cancer

Sponsor: California Institute for Regenerative Medicine (CIRM)

Conditions Advanced Cancer
Interventions CFI-400945
Updated 14 times since 2017 Last updated: Jan 14, 2024 Started: Mar 31, 2014 Primary completion: Jul 31, 2021 Completion: Jul 22, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01954316, this PHASE1 trial focuses on Advanced Cancer and remains completed. Sponsored by California Institute for Regenerative Medicine (CIRM), it has been updated 14 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Jun 2019 · 4 months · monthly snapshot~Jun 2019 – ~Feb 2020 · 8 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Jun 2022 · 16 months · monthly snapshot~Jun 2022 – ~Feb 2023 · 8 months · monthly snapshot~Feb 2023 – ~May 2023 · 3 months · monthly snapshot~May 2023 – ~Feb 2024 · 9 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Feb 2024 — Jul 2024 [monthly]

    Completed PHASE1

  4. May 2023 — Feb 2024 [monthly]

    Completed PHASE1

  5. Feb 2023 — May 2023 [monthly]

    Completed PHASE1

▶ Show 9 earlier versions

  1. Jun 2022 — Feb 2023 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  2. Feb 2021 — Jun 2022 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1

  4. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  5. Jun 2019 — Feb 2020 [monthly]

    Recruiting PHASE1

  6. Feb 2019 — Jun 2019 [monthly]

    Recruiting PHASE1

  7. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE1

  8. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • California Institute for Regenerative Medicine (CIRM)
  • The Princess Margaret Cancer Foundation
  • University Health Network, Toronto
Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations